2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Patent Ductus Arteriosus: new trials by email Literature Review of Patent Ductus Arteriosus trials Research Report on Patent Ductus Arteriosus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates optimized ibuprofen, Standard Ibuprofen - Patent Ductus Arteriosus | Phase 4 | Terminated | OSF Healthcare System | 10 | 2009-08-01 | 2014-01-28 |
| Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants Survanta (beractant), Curosurf (poractant) - Prematurity, Respiratory Distress Syndrome | Phase 4 | Terminated | Alan Fujii | 52 | 2005-01-01 | 2011-10-03 |
Ductus Arteriosus, Patent (2) · Premature Birth (2) · Respiratory Distress Syndrome (1)
Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Heart Defects, Congenital (2) · Heart Diseases (2) · Obstetric Labor Complications (2) · Obstetric Labor, Premature (2) · Pregnancy Complications (2) · Urogenital Diseases (2) · Lung Diseases (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1)
Ibuprofen (1) · beractant (1) · poractant alfa (1)
Alan Fujii (1) · OSF Healthcare System (1)
United States (2)
Alan M Fujii, MD (1) · James R Hocker, MD (1)